NEW YORK, Sept. 16 (GenomeWeb News) - RheoGene has licensed its RheoSwitch System technology to Xenogen Biosciences to develop transgenic mice as animal research models.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
